Chairpersons :

Shishir Shetty, S. D. Banavali, Anil Sanganeria

Reviewer :

Nita Nair

1. Randomized comparison of adjuvant aromatase inhibitor Exemestane (E) plus Ovarian Function Suppression (OFS) vs Tamoxifen (T) plus OFS in premenopausal women with Hormone Receptor positive (HR+) early Breast Cancer (BC): Update of the combined TEXT and SOFT trials Author: Francis PA Citation: SABCS Abstract GS4-02

2. Randomized comparison of adjuvant Tamoxifen (T) plus Ovarian Function Suppression (OFS) versus tamoxifen in premenopausal women with Hormone Receptor-positive (HR+) early Breast Cancer (BC): Update of the SOFT trial Author: Fleming G. Citation: SABCS Abstract GS4-03

3. Pooled analysis of five randomized trials investigating temporary ovarian suppression with gonadotropin-releasing hormone analogs during chemotherapy as a strategy to preserve ovarian function and fertility in premenopausal early breast cancer patients Author: Lambertini M. Citation: SABCS Abstract GS4-01